title: Self-treatment of benign paroxysmal positional vertigo with DizzyFix, a new dynamic visual device.
abstract: Benign paroxysmal positional vertigo is one of the most common disorders of the vestibular system. It is characterized by episodes of recurrent vertigo triggered by head movements or position changes associated with nystagmus. There is scientific evidence that in the majority of cases this condition responds well to the particle repositioning maneuver (PRM) correctly performed by the physician. However, the PRM needs to be repeated in approximately 30% of the cases. Although the maneuver is simple, patients often find it difficult to perform correctly as self-treatment, with the result that it fails to bring about an improvement in the symptoms. DizzyFix (Clearwater Clinical Limited, Canada) is the name given to a new dynamic visual device designed to provide a visual representation of the PRM based on the canalith theory. The DizzyFiX consists of a specially curved acrylic tube containing a nontoxic viscous fluid and a bead, the purpose of which is to help the patient and the inexperienced physician to perform the PRM correctly. A randomized clinical trial has shown that it reliably enables the maneuver to be performed correctly, and a study investigating the effectiveness of patient self-treatment of benign paroxysmal positional vertigo with the device in comparison with standard office treatment revealed both techniques to be equally effective. The device has now been approved by the US FDA.
authors.affiliation: Private ENT Clinic Goettingen, University Witten/Herdecke, Faculty of Medicine, Goettingen, Germany. dr.d.brehmer@t-online.de
authors.forename: Detlef
authors.initials: D
authors.lastname: Brehmer
mesh_terms: D006801:Humans; D016896:Treatment Outcome; D014717:Vertigo / Q000601:surgery / Q000628:therapy*; D057488:Visual Prosthesis / Q000009:adverse effects; D057832:Watchful Waiting